MedTrace Logo

A Study Conducted Over 3 Periods to Look at the Drug in the Body

NCT01225939 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2011-03-02

No results posted yet for this study

Summary

A study conducted over 3 periods to look at the drug in the body.

Conditions

Interventions

DRUG

AZD8329

tablet

DRUG

AZD8329

Solution

Sponsors & Collaborators

Principal Investigators

  • J Ritter, BM BCh, MRCP, FRCP · Quintiles Drug Research Unit at Guy's Hospital

  • Dr. Mirjana Kujacic · AstraZeneca Mölndal

  • Jan Eriksson, MD PhD · AstraZeneca Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United Kingdom

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01225939 on ClinicalTrials.gov